Emphasis in treating osteoporosis has been on T-scores rather than overall fracture risk. Fracture Risk Assessment Tool (FRAX) supports a risk sensitive approach to osteoporosis treatment by providing an absolute fracture risk. FRAX combined with a decision aid may promote a shared decision making approach with patients, allowing the clinician and patient to weigh potential fracture risk (without treatment), versus risk reduction with medication (including side effects and costs). OSTEOPOROSIS CHOICE II will test the effectiveness of: * FRAX * FRAX + decision aid * Usual care (no decision aid and no FRAX given to clinician)
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
79
Clinicians will present patient's with their individualized risk of osteoporotic fracture in 10 years, based on the FRAX risk calculator, as well as sharing a decision aid with them, which shows their risk of fracture, risk reduction on medications, as well as the downsides of the medications.
The clinician is provided with the patient's estimated risk of fracture as computed by the FRAX
Mayo Clinic
Rochester, Minnesota, United States
Mayo Clinic
Rochester, Minnesota, United States
Medication start/stop, knowledge, and patient involvement.
Time frame: Baseline and at 6 months
Decisional quality.
Time frame: Baseline and at 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.